The global diabetes care drugs industry is witnessing substantial expansion due to the rising burden of diabetes across developed and emerging economies. Increasing cases of Type 1 and Type 2 diabetes, changing dietary patterns, sedentary lifestyles, and aging populations are contributing to higher demand for advanced treatment solutions. Pharmaceutical companies are actively investing in...